Skip to main content
OpenTrials
Completed

NCT Number: NCT04256746

Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose

Randomized, balanced incomplete block design dose response study of efficacy, with 4 different dosages of mulberry fruit powdered extract added to cooked rice compared to a reference treatment (cooked rice only).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lambda Therapeutics Research Ttd (LTRL)

Ahmedabad, Gujarat, 382481, India

About this study

Dose response study with 4 dosages of mulberry fruit powdered extract (0.37, 0.75, 1.12 and 1.5 g) added to cooked rice, compared to cooked rice only(reference) on post prandial blood glucose response in healthy Indian adults.

In addition, 1.5 g of mulberry fruit powdered extract was added to instant rice porridge and compared to instant rice porridge only as positive control (replication of previous research.

In total there were 7 test products in the study: 5 active treatments and 2 reference treatments.

The study was a cross-over study (4 interventions per subject, 4 out of the 7 test products). The recovery period between treatments was at least seven days.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Willing to give consent to participate in the study in writing;
  • Healthy male and female subjects between ≥ 20 and ≤ 50.0 years of age;
  • BMI of ≥18.0 and ≤ 25.0 kg/m2;
  • Apparently healthy: no medical conditions which might effect study measurements as judged by the study physician or measured by questionnaire, and/or assessed by hematology, blood chemistry and urinalysis;
  • Willing to comply to study protocol during the study;
  • Agreeing to be informed about medically relevant personal test-results by study physician;
  • Willing to refrain from drinking of alcohol on and one day before the blood withdrawal;
  • Fasting blood glucose value of volunteer is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening;
  • Haemoglobin level within clinically acceptable range (for male 12 to 17 gm/dL and for females 11 to 15 gm / dL; both inclusive) as judged by the research physician.

Exclusion criteria

  • Being an employee of Unilever of Lambda;
  • Chronic smokers, tobacco chewers and drinkers;
  • Participation in any other biomedical study 3 months before screening visit day of this study and/or participating in any other biomedical study during the screening period;
  • High intake of alcohol (>120 mL/week);
  • Reported use of medically prescribed/slimming diet;
  • Reported participation in night shifts (between 23.00 and 6.00 hrs);
  • Use of medication which interferes with study measurements including vitamins, tonics;
  • Reported intense exercise ≥10 h/week;
  • Reported weight loss/gain ≥ 10% of body weight in the 6 months preceding screening
  • Blood donation for 2 months prior to screening;
  • Urine analysis that showed any drug abuse;
  • Allergy to any food or cosmetics;
  • If female, not being pregnant or planning pregnancy during the study period;
  • If female, lactating or has been lactating for 6 weeks before pre-study investigation and/or during the study period.

Treatment and study plan

Boiled Rice

Other

Boiled Rice+0.37 gr mulberry fruit powdered extract

Other

Boiled Rice+0.75 gr mulberry fruit powdered extract

Other

Boiled Rice+1.12 gr mulberry fruit powdered extract

Other

Boiled Rice+1.50 gr mulberry fruit powdered extract

Other

Rice Porridge

Other

Rice porridge+1.50 gr mulberry fruit powdered extract

Other

Primary outcomes

  1. Post-prandial blood glucose

    Time frame: Positive incremental Area under the glucose versus time Curve between 0 (before) and 2 hours after test product intake

    Glucose concentration in venous plasma

Secondary outcomes

  1. Post-prandial insulin

    Time frame: Total area under the insulin versus time curves between 0 (before) and 2 hours after study product intake

    Post-prandial serum insulin

Other outcomes

  1. Hydrogen gas in exhaled breath

    Time frame: Analyzed before study product administration at 20 minutes before and at 65, 125, 185, 245, 305, 365 and 425 minutes after the ingestion of the study products

    Each time a volunteer produced a 10 ppm hydrogen (or more) above the basal breath hydrogen level during the 7-hour test period, the value was regarded as a "positive".

  2. Intestinal discomfort

    Time frame: Just before and at 430 minutes after study product administration

    A questionnaire to assess four aspects of intestinal discomfort (bloating, flatulence, nausea and pain) on scale from 0-3 was completed by the subjects

Sponsors and collaborators

Lead sponsor

Unilever R&D

Industry

Collaborators

  • Lambda Therapeutic Research Ltd.

Registry information

Official study title

A Natural Extract for Reducing the Post Prandial Blood Glucose Response in Healthy Indian Adults: A Dose-response Study of Efficacy and Tolerance

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Feb 5, 2020
Registry last updated
Feb 5, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.